ClinicalTrials.gov
public full text
Public Domain
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma#872547
- Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children#910627
- A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss#1138666
- Postoperative Lebensqualität: Hemithyreoidektomie und Thyreoidektomie im Vergleich#345750
- A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION#471463
Record · ID 290994
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive